The Global Laboratory Initiative (GLI) is a network of international partners dedicated to accelerating and expanding access to quality assured laboratory services in response to the diagnostic challenges of TB, notably HIV-associated and drug-resistant TB. The GLI provides a focus for TB within the framework of a multi-faceted yet integrated approach to laboratory capacity strengthening.
Information Notes

Practical considerations for implementation of the Abbott RealTime MTB and Abbott RealTime MTB RIF/INH tests


Practical considerations for implementation of the Roche cobas MTB and cobas MTB-RIF/INH assays


Practical considerations for implementation of the Bruker-Hain Lifesciences FluoroType MTB and FluoroType MTBDR

GLI Working Group Secretariat
Global TB Programme
World Health Organization
Geneva, Switzerland
Email: gli_secretariat@who.int